Revolutionizing treatment for patients in need

View Our Pipeline
Scroll To Discover
smiling Tarsus woman smiling Tarsus woman smiling Tarsus woman

About

We’re committed to delivering boundless therapeutic ingenuity

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of diseases with limited treatment options.

Discover Tarsus

Product

Novel therapies, beginning with the eye

For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is here.

Learn more

News & Media

Here is the latest from Tarsus

11/09/2023 Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements
11/01/2023 Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
09/06/2023 Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis

Contact Tarsus

Please reach out to us using the form below.

"*" indicates required fields

Opt-in
This field is for validation purposes and should be left unchanged.